LV12449A - Udens suspensija nazalai lietosanai - Google Patents

Udens suspensija nazalai lietosanai

Info

Publication number
LV12449A
LV12449A LV990109A LV990109A LV12449A LV 12449 A LV12449 A LV 12449A LV 990109 A LV990109 A LV 990109A LV 990109 A LV990109 A LV 990109A LV 12449 A LV12449 A LV 12449A
Authority
LV
Latvia
Prior art keywords
suspension
loteprednol etabonate
water suspension
nasal use
dermal
Prior art date
Application number
LV990109A
Other languages
English (en)
Other versions
LV12449B (lv
Inventor
Koji Doi
Original Assignee
Bodor Nicholas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Nicholas filed Critical Bodor Nicholas
Publication of LV12449A publication Critical patent/LV12449A/lv
Publication of LV12449B publication Critical patent/LV12449B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
LVP-99-109A 1997-01-16 1999-07-15 Ūdens suspensija nazālai lietošanai LV12449B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16
PCT/JP1998/000108 WO1998031343A2 (en) 1997-01-16 1998-01-14 Aqueous suspension for nasal administration of loteprednol

Publications (2)

Publication Number Publication Date
LV12449A true LV12449A (lv) 2000-04-20
LV12449B LV12449B (lv) 2000-09-20

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-109A LV12449B (lv) 1997-01-16 1999-07-15 Ūdens suspensija nazālai lietošanai

Country Status (33)

Country Link
US (1) US6368616B1 (lv)
EP (1) EP0973501B1 (lv)
KR (1) KR100471708B1 (lv)
CN (1) CN1126535C (lv)
AR (1) AR011773A1 (lv)
AT (1) ATE249205T1 (lv)
AU (1) AU730953C (lv)
BR (1) BR9806771A (lv)
CA (1) CA2278025C (lv)
CZ (1) CZ294919B6 (lv)
DE (1) DE69818026T2 (lv)
DK (1) DK0973501T3 (lv)
EA (1) EA001775B1 (lv)
ES (1) ES2206880T3 (lv)
HK (1) HK1026138A1 (lv)
HU (1) HU226613B1 (lv)
ID (1) ID21892A (lv)
IL (1) IL130979A0 (lv)
LT (1) LT4677B (lv)
LV (1) LV12449B (lv)
MX (1) MXPA99006628A (lv)
NO (1) NO324619B1 (lv)
NZ (2) NZ336990A (lv)
PL (1) PL190753B1 (lv)
PT (1) PT973501E (lv)
RS (1) RS49701B (lv)
SI (1) SI20057A (lv)
SK (1) SK283164B6 (lv)
TR (1) TR199901663T2 (lv)
TW (1) TW503113B (lv)
UA (1) UA52722C2 (lv)
WO (1) WO1998031343A2 (lv)
ZA (1) ZA98303B (lv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP4338313B2 (ja) * 1998-08-26 2009-10-07 帝人株式会社 粉末状経鼻組成物
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
DK1406633T3 (da) * 2001-06-18 2011-10-31 Noven Pharma Forbedret lægemiddeltilførsel i transdermale systemer
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
ATE369138T1 (de) * 2003-06-19 2007-08-15 Nicholas S Bodor Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden
CN1838960A (zh) 2003-06-19 2006-09-27 尼古拉斯·S·博多尔 局部应用的温和抗炎类固醇的活性和/或作用时间的增强
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
BRPI0509220A (pt) 2004-03-25 2007-09-04 Bausch & Lomb método, formulação oftálmica e kit para para o tratamento de olho ressecado moderno a grave; método para o tratamento de olho ressecado crÈnico; e métodos para reduzir a vermelhidão e a produção de citocinas inflamatórias por células no epitélio
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
AU2018321157B2 (en) 2017-08-24 2024-03-28 Novo Nordisk A/S GLP-1 compositions and uses thereof
IL294520A (en) 2020-02-18 2022-09-01 Novo Nordisk As Pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
IL130979A0 (en) 2001-01-28
WO1998031343A3 (en) 1998-09-17
CZ237499A3 (cs) 2000-01-12
AU730953C (en) 2002-02-07
ES2206880T3 (es) 2004-05-16
TW503113B (en) 2002-09-21
KR20000070214A (ko) 2000-11-25
NZ336990A (en) 2001-03-30
CA2278025C (en) 2005-09-06
RS49701B (sr) 2007-12-31
CZ294919B6 (cs) 2005-04-13
LT4677B (lt) 2000-07-25
WO1998031343A2 (en) 1998-07-23
CA2278025A1 (en) 1998-07-23
SK283164B6 (sk) 2003-03-04
HUP0002473A2 (hu) 2000-12-28
PL334614A1 (en) 2000-03-13
DE69818026T2 (de) 2004-07-08
TR199901663T2 (xx) 1999-09-21
KR100471708B1 (ko) 2005-03-07
HK1026138A1 (en) 2000-12-08
EP0973501A2 (en) 2000-01-26
MXPA99006628A (es) 2005-01-10
LV12449B (lv) 2000-09-20
EA001775B1 (ru) 2001-08-27
ZA98303B (en) 1998-07-20
CN1250370A (zh) 2000-04-12
LT99100A (en) 2000-02-25
EA199900659A1 (ru) 2000-02-28
NZ509908A (en) 2004-12-24
AU730953B2 (en) 2001-03-22
EP0973501B1 (en) 2003-09-10
YU36199A (sh) 2002-09-19
HUP0002473A3 (en) 2001-01-29
NO324619B1 (no) 2007-11-26
BR9806771A (pt) 2000-05-16
SK94899A3 (en) 2000-05-16
AR011773A1 (es) 2000-09-13
AU5495298A (en) 1998-08-07
PL190753B1 (pl) 2006-01-31
US6368616B1 (en) 2002-04-09
ATE249205T1 (de) 2003-09-15
PT973501E (pt) 2004-02-27
DK0973501T3 (da) 2004-01-19
ID21892A (id) 1999-08-05
NO993453L (no) 1999-07-13
DE69818026D1 (de) 2003-10-16
NO993453D0 (no) 1999-07-13
HU226613B1 (en) 2009-04-28
UA52722C2 (uk) 2003-01-15
SI20057A (sl) 2000-04-30
CN1126535C (zh) 2003-11-05

Similar Documents

Publication Publication Date Title
LV12449A (lv) Udens suspensija nazalai lietosanai
DK0814782T3 (da) Farmaceutisk præparat stabiliseret med et basisk middel
BR0210205A (pt) Antiinfecciosos
NO20022201L (no) Lösninger inneholdende Epinastin
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
WO2004045453A3 (en) Absorbent neck shield
CA2411582A1 (en) Method for increasing the antioxidative potential of selenium-containing aqueous solutions
ATE254851T1 (de) Iod-herstellungszusammensetzung
NO20005281D0 (no) Meget rene vandige hydrogenperoksidoppløsninger, fremgangsmÕte for fremstilling derav samt anvendelse av oppløsningene
CA2361929A1 (en) Liquid deodorant
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
JP2000034347A5 (lv)
ATE326215T1 (de) Verwendung einer wässrigen lösung oder suspension zum heilen des hornhautepithels
CN213123740U (zh) 一种反扣式义甲固定带
EE04623B1 (et) Ühendusdetail
PT1330246E (pt) Utilizacao de derivados do acido hidroxieicosatetraenoico em cirurgia intraocular
GB9807491D0 (en) An aqueous solution
AU2002100363A4 (en) Snore no more
JPS5448745A (en) Preparation of n-2-fluorenesulfonylamino acid
WO2002034246A3 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
GR77250B (lv)
JP3067696U (ja) 包茎矯正具
TH43265A (th) สารแขวนลอยในน้ำสำหรับการใช้ทางจมูก